132 related articles for article (PubMed ID: 6883305)
1. Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
Karle JM; Hoerauf RM; Cysyk RL
Cancer Lett; 1983 Jun; 19(2):147-57. PubMed ID: 6883305
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
3. Isotope-dilution analysis of rate-limiting steps and pools affecting the incorporation of thymidine and deoxycytidine into cultured thymus cells.
Sjostrom DA; Forsdyke DR
Biochem J; 1974 Feb; 138(2):253-62. PubMed ID: 4274611
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
5. Ara-C metabolism: implications for drug resistance and drug interactions.
Chabner BA; Hande KR; Drake JC
Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
Chabot GG; Bouchard J; Momparler RL
Biochem Pharmacol; 1983 Apr; 32(7):1327-8. PubMed ID: 6189497
[No Abstract] [Full Text] [Related]
7. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
8. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
[TBL] [Abstract][Full Text] [Related]
9. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
McPartland RP; Wang MC; Bloch A; Weinfeld H
Cancer Res; 1974 Nov; 34(11):3107-11. PubMed ID: 4472653
[No Abstract] [Full Text] [Related]
10. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
Momparler RL; Momparler LF
Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
[TBL] [Abstract][Full Text] [Related]
12. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia model.
Grem JL; Plowman J; Rubinstein L; Hawkins MJ; Harrison SD
Leuk Res; 1991; 15(4):229-36. PubMed ID: 2030604
[TBL] [Abstract][Full Text] [Related]
14. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
15. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Moriconi WJ; Slavik M; Taylor S
Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.
Momparler RL; Bouffard DY; Momparler LF; Marquet J; Zittoun J; Marie JP; Zittoun R
Int J Cancer; 1991 Oct; 49(4):573-6. PubMed ID: 1917159
[TBL] [Abstract][Full Text] [Related]
17. Modulation of metabolism of cytosine arabinoside in L cells by antibody and complement.
Shearer WT; Green CG; Mettes HJ
Immunopharmacology; 1983 Oct; 6(3):203-14. PubMed ID: 6629738
[TBL] [Abstract][Full Text] [Related]
18. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
Heinemann V; Plunkett W
Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
[TBL] [Abstract][Full Text] [Related]
19. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; VeselĂ˝ J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
20. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
Snyder RD; Malick NC
Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]